Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Notter

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
The Journal of Clinical Investigation|March 1, 1996
Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in miceU Kunzendorf, T Pohl, S Bulfone-Paus, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 1, 1996
[2 unusual cutaneous T-cell lymphomas with extracutaneous involvement]S Goerdt, J Ramaker, U Sonner, et al.
Tissue & Cell|November 10, 2004
Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary studyA A Hegewald, J Ringe, J Bartel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell linesZ Gazit, D W Weiss, D Shouval, et al.
Leukemia|June 1, 1995
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemiasH D Menssen, H J Renkl, U Rodeck, et al.
Oncogene|September 20, 2005
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growthM R Bhonde, M-L Hanski, M Notter, et al.
Leukemia & Lymphoma|October 1, 1996
Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomasW U Knauf, M P Koenigsmann, M Notter, et al.
Transplantation|May 8, 2000
An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppressionS Bulfone-Paus, R Rückert, H Krause, et al.
Cancer Research|July 14, 1998
Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejectionS Bulfone-Paus, H von Bernuth, R Rückert, et al.
International Journal of Oncology|May 17, 2011
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivoM Topp, M Koenigsmann, A Miresluis, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
The Journal of Clinical Investigation|March 1, 1996
Suppression of cell-mediated and humoral immune responses by an interleukin-2-immunoglobulin fusion protein in miceU Kunzendorf, T Pohl, S Bulfone-Paus, et al.
Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|March 1, 1996
[2 unusual cutaneous T-cell lymphomas with extracutaneous involvement]S Goerdt, J Ramaker, U Sonner, et al.
Tissue & Cell|November 10, 2004
Hyaluronic acid and autologous synovial fluid induce chondrogenic differentiation of equine mesenchymal stem cells: a preliminary studyA A Hegewald, J Ringe, J Bartel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Chemo-adoptive immunotherapy of nude mice implanted with human colorectal carcinoma and melanoma cell linesZ Gazit, D W Weiss, D Shouval, et al.
Leukemia|June 1, 1995
Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemiasH D Menssen, H J Renkl, U Rodeck, et al.
Oncogene|September 20, 2005
Equivalent effect of DNA damage-induced apoptotic cell death or long-term cell cycle arrest on colon carcinoma cell proliferation and tumour growthM R Bhonde, M-L Hanski, M Notter, et al.
Leukemia & Lymphoma|October 1, 1996
Peripheral blood progenitor cell mobilization with Dexa-Beam/G-CSF, ether lipid purging, and autologous transplantation after high-dose CBV treatment: a safe and effective regimen in patients with poor risk malignant lymphomasW U Knauf, M P Koenigsmann, M Notter, et al.
Transplantation|May 8, 2000
An interleukin-2-IgG-Fas ligand fusion protein suppresses delayed-type hypersensitivity in mice by triggering apoptosis in activated T cells as a novel strategy for immunosuppressionS Bulfone-Paus, R Rückert, H Krause, et al.
Cancer Research|July 14, 1998
Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejectionS Bulfone-Paus, H von Bernuth, R Rückert, et al.
International Journal of Oncology|May 17, 2011
Interleukin-4 inhibits growth of a human lung-tumor cell-line in-vitro and has therapeutic activity against xenografts of this cell-line in-vivoM Topp, M Koenigsmann, A Miresluis, et al.
Pageof 5